Doximity Inc is a digital platform designed specifically for medical professionals, primarily physicians, to enhance communication and collaboration within the healthcare community
The platform provides a range of tools and resources, including secure messaging, telehealth services, and access to a network of healthcare professionals, allowing doctors to connect with each other and stay updated on medical news and developments. Additionally, Doximity offers features such as electronic faxing, a comprehensive directory of healthcare providers, and opportunities for continuing medical education, all aimed at improving clinical workflows and ultimately enhancing patient care.
Mid-to-large-cap stocks like BROS, DOCS, and HOOD have seen substantial gains as the market rewards positive earnings from mid to modest large-cap stocks.
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Feb. 3-7, 2025.
Shares of healthcare professional network Doximity (NYSEDOCS)
jumped 37.6% in the afternoon session after the company reported strong fourth-quarter results, and handily beat on the revenue, EBITDA, and EPS lines. Top line growth accelerated by 24% year on year, as the quarter benefited from strong platform engagement with over 610,000 providers using its clinical workflow tools and a 60% sequential growth in AI tool usage. Doximity also provided optimistic EBITDA guidance for the next quarter, which blew past analysts' expectations. Zooming out, we think this was a very good quarter with some key areas of upside.
Wondering how the US markets performed one hour before the close of the markets on Friday? Discover the movers and shakers of today's session in our comprehensive analysis.
Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.
Healthcare professional network Doximity (NYSEDOCS) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 24.6% year on year to $168.6 million. On top of that, next quarter’s revenue guidance ($133 million at the midpoint) was surprisingly good and 4.7% above what analysts were expecting. Its non-GAAP profit of $0.45 per share was 34% above analysts’ consensus estimates.
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
